期刊文献+

恶性血液病中组织因子微粒与血栓形成的研究进展 被引量:1

Advances in the relationship between tissue factor bearing microparticles and thrombosis in hematologic malignancies
原文传递
导出
摘要 自1985年Trousseau首次发现血栓与癌症的相关性以来,一系列研究证实各种肿瘤均与血栓形成有关;特别是在恶性血液病中,出血并发症往往占主要地位,从而使人们忽略了血栓并发症。实际上恶性血液病除了本身疾病进展危及生命外,患者还存在出血与血栓的危险性,即血栓出血综合征,严重威胁患者生命。 Hematologic malignancies also occur with bleeding and thrombosis complications in addition to their own progress of disease.Thrombosis affects not only the treatment but also the prognosis of patients.Microparticles are fragments derived from activated and apoptotic cells.Tissue factor bearing microparticles may be associated with thrombosis in hematologic malignancies.Study on the relationship between them may have an important role in the treatment and prognosis of disease.
出处 《临床血液学杂志》 CAS 2014年第A02期254-256,共3页 Journal of Clinical Hematology
基金 卫生公益性行业科研专项(No:201202017)
关键词 恶性血液病 组织因子微粒 血栓 hematologic malignancies tissue factor bearing microparticles thrombosis
  • 相关文献

参考文献20

  • 1周莉莉,韩悦,朱倩,胡璐萍,赵世香,朱明清,戴兰,沈文红,陈黎,吴德沛.组织因子微颗粒的检测及其在出凝血异常中的临床意义[J].中国实验血液学杂志,2012,20(4):937-940. 被引量:4
  • 2唐云龙,周燕,王纯斌,秦燕,冯健,秦婧.组织因子相关血小板微粒对恶性淋巴瘤患者血栓发生的提示作用[J].中国实验血液学杂志,2012,20(2):325-328. 被引量:4
  • 3汪蕾,胡钧培,叶为德.沙利度胺对血液肿瘤患者致栓作用的初步探究[J].血栓与止血学,2010,16(3):124-126. 被引量:8
  • 4Jeffrey I. Zwicker,Cameron C. Trenor,Barbara C. Furie,Bruce Furie.Tissue Factor–Bearing Microparticles and Thrombus Formation[J].Arteriosclerosis Thrombosis and Vascular Biology.2011(4)
  • 5Hau Kwaan,Eduardo Magalh?es Rego.Role of Microparticles in the Hemostatic Dysfunction in Acute Promyelocytic Leukemia[J].Semin Thromb Hemost.2010(08)
  • 6Danijela Lekovic,Predrag Miljic,Biljana Mihaljevic.Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma[J].Thrombosis Research.2010(6)
  • 7J.ZHOU,J.SHI,J.HOU,F.CAO,Y.ZHANG,J. T.RASMUSSEN,C. W.HEEGAARD,G. E.GILBERT.Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia[J].Journal of Thrombosis and Haemostasis.2010(4)
  • 8A. A.KHORANA,C. W.FRANCIS,K. E.MENZIES,J.‐G.WANG,O.HYRIEN,J.HATHCOCK,N.MACKMAN,M. B.TAUBMAN.Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer[J].Journal of Thrombosis and Haemostasis.2008(11)
  • 9Salam Alkindi,David Dennison,Anil Pathare.Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma[J].Archives of Medical Research.2008(2)
  • 10A. S.Leroyer,A.Tedgui,C. M.Boulanger.Role of microparticles in atherothrombosis[J].Journal of Internal Medicine.2008(5)

二级参考文献25

  • 1ERIKSSON T, BJORKMAN S, HOGLUND P. Clinical pharmacology of thalidomide[ J]. Eur J Clin Phamlacol,2001,57 (5) :365-376.
  • 2RAJKUMAR SV. Current status of thalidomide in the treatment of cancer[J]. Oncology(Huntingt) ,2001,15(7) :867-874.
  • 3OSMAN K, COMENZO R, RAJKUMAR SV. Deep venous thrombosis and thalidomide therapy for multiple myeloma[ J]. N Engl J Med, 2001,344(25) :1951-1952.
  • 4MEIERHOFER C, DUNZENDORFER S, WIEDERMANN C J. Theoretical basis for the activity of thalidomide[ J]. BioDrugs,2001,15 (10) :681-703.
  • 5GACHON J, GROB JJ, RICHARD MA. Thrombotic accidents induced by thalidomide: two cases [ J ]. Rev Med Interne,2002,23 : 724.
  • 6Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol,2003 ;72 ( 1 ) :43 -52.
  • 7Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis and management. Hematol Oncol Clin North Am,2005 ; 19 ( 1 ) : 183 - 202.
  • 8Hugel B, Martinez MC, Kunzelmann C, et al. Membrane microparticles : two sides of the coin. Physiology ( Bethesda ), 2005 ;20:22 - 27.
  • 9Ahn YJ, Jy W, Jimenez JJ, et al. Moreon: cellular microparticles:what are they bad or good for? J Thromb Haemost, 2004 ;2 (7) : 1215 - 1216.
  • 10Zwiker JI, Furie BC, Furie B. Cancer-associated thrombosis. Circulation,2003 ; 107 (23) : 14 - 18.

共引文献13

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部